Stage II Colorectal Cancer: To Treat or not to Treat-Reference-Cited by-同舟云学术

Stage II Colorectal Cancer: To Treat or not to Treat

Published:2005-05-01 Issue:5 Volume:10 Page:332-334
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Johnston Patrick G.¹

Affiliation:

1. Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.10-5-332

Reference15 articles.

1. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

2. Adjuvant therapy for patients with colon and rectal cancer;NIH consensus conference;JAMA,1990

3. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, C-04);Mamounas;J Clin Oncol,1999

4. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer; who benefits and by how much?;Gill;J Clin Oncol,2004

5. Adjuvant therapy with oral fluoropyrimidines after curative resection for colorectal cancer. Individual patient data meta-analysis of randomized trials;Sakamoto;Proc Am Soc Clin Oncol,2001

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the hidden link between oral flora and colorectal cancer: a bidirectional Mendelian randomization analysis and meta-analysis;Frontiers in Microbiology;2024-09-10

2. Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans;JAMA Health Forum;2024-05-31

3. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer;Journal of Cancer Research and Clinical Oncology;2024-03-23

4. A mathematical model with fractional-order dynamics for the combined treatment of metastatic colorectal cancer;Communications in Nonlinear Science and Numerical Simulation;2024-03

5. KMT2A Mutations and High Prevalence of dMMR-associated Mutational Signatures as Prognostic Indicators in Metastatic Colorectal Cancer;Journal of Cancer;2024